Reshma Kewalramani - 30 Sep 2022 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role
Director
Signature
/s/ Karen Tepichin, Attorney-in-Fact
Issuer symbol
DNA
Transactions as of
30 Sep 2022
Net transactions value
$0
Form type
4
Filing time
10 Nov 2022, 16:30:27 UTC
Previous filing
17 Aug 2022
Next filing
27 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNA Class A Common Stock Options Exercise +9,818 +14% 80,739 30 Sep 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNA Restricted Stock Units Options Exercise $0 -9,818 -100% $0.000000* 0 30 Sep 2022 Class A Common Stock 9,818 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the conversion of restricted stock units ("RSUs") into Class A common stock.
F2 Each RSU represents a contingent right to receive one share of Class A common stock.
F3 In accordance with an agreement between the Reporting Person and the issuer to delay vesting of the RSUs, the RSUs vested on September 30, 2022.